Home Analyst Ratings Humana Inc. Upgraded to Outperform at RBC Capital

Humana Inc. [HUM] Upgraded to Outperform at RBC Capital

RBC Capital took its Humana Inc. [NYSE:HUM]‎‎ rating to the equivalent of Outperform from Sector ‎Perform, ‎and the price target ‎to $479 from $429, ‎in a research note dated January 4, 2021. That figure ‎represents around a 16.75% ‎premium ‎from ‎where the company’s shares closed on Thursday.‎ Some ‎new analysts also started their ‎coverage, with Bernstein’s analysts assigning the shares to “a Mkt ‎perform” rating in a research note ‎to investors issued in early October. Meanwhile, SVB Leerink had ‎launched its coverage on HUM with ‎‎”an Outperform”, in a research note produced for clients July 01, ‎‎2020. In addition, there was a ‎downgrade from Cowen on June 16, 2020. The rater changed HUM from ‎‎”an Outperform” to “a ‎Market perform”.

Get the hottest stocks to ‎trade every day before the ‎market opens 100% free. Click here now. ‎‎

Is ‎Humana Inc. [NYSE:HUM] a Good Buy Right Now?

It should be noted that HUM ‎technical ‎indicators for short, intermediate as well as long term progress have placed an overall ‎average of 8% as ‎Buy. The average signal changed from 8% Buy in the last week and compares with ‎‎40% Buy in the past ‎month. Data from Humana Inc.’s Trend Spotter indicated that the signals were ‎Weakest. The stock ‎current average is 0.82 million shares in the past 20 days and the short term ‎average signal indicates a ‎Hold. In the last 50 days, the average trading volume was 0.85 million shares ‎while the medium term ‎average advocated for Hold. The average long-term signal stands at 50% Buy ‎and the 100-day average ‎volume stands at 0.72 million shares.‎‎

HUM Price Performance

On ‎Wall Street, Humana Inc. [NYSE:HUM] finished Thursday’s ‎session up 1.02% at $410.27. The stock went ‎up to $411.01 at the same session while its lowest single ‎day price was $403.30. In the last five days, it ‎saw a rise of about 1.28%, Humana Inc. shares gained by ‎almost 11.94% since the beginning of the ‎year. However, the share price has dropped to as low as -‎‎13.57% below its one year high. On 11/04/20, ‎the company shares recorded $474.70, the highest ‎single-day price it has got to in the last 52-weeks ‎and a 52-week low was seen on 03/23/20, the same ‎year at $208.25. The company’s shares have ‎inclined by 12.95% in the past year. The 50-day SMA ‎achieved is $412.61 while the 200-day SMA is ‎‎$391.77. Volume gained to 0.56 million from 0.53 million in ‎the previous session.‎‎

Humana Inc. ‎‎[HUM] Valuation Measures

Notably, Humana Inc. [HUM] stock can be ‎classified as a good ‎candidate in the listing of underestimated low-priced Healthcare Plans companies ‎to purchase soonest ‎possible with the prevailing 12-month PE ratio of 13.15. The measure means the ‎stock is exchanging at ‎a discount as compared to the 16.72x trailing earnings of the industry. It can be ‎helpful for investors to ‎consider historical price-sales ratio, more specifically, a 0.72 PS value ratio is ‎reported for the last one ‎year of reported earnings. That is lower than the industry average of 0.73 ‎which means HUM serve an ‎attractive investment opportunity compared to its competitors.‎‎

HUM Stock Support And ‎Resistance Levels

On the 24-hour scale, the immediate backing is ‎perceived around 405.38 level, ‎and in case of violation of this particular level, it will cause more drop to ‎‎400.48 level. On the upper ‎level, 415.90 is still the key resistance. The stock may increase to the ‎subsequent resistance at 413.09. ‎The Relative Strength Index (RSI) pinned on the 14-day chart is 54.78, ‎implying a neutral technical ‎stance while the MACD stands at 9.97, meaning price will increase in the ‎next trading period. Percent R ‎indicator moved to 11.47%, implying bullish price movement. Stochastic ‎‎%K at 82.05% suggest selling ‎the stock.‎‎

What is the short interest in Humana Inc.?

Short interest in the Humana Inc. stock ‎has ‎surged, increasing by 0.54 million shares to total 1.46 million shares on Dec 14, 2020. The interest ‎had ‎seen shares on Nov 12, 2020 stand at 2.0 million, data from Yahoo Finance shows. The decrease of ‎‎-‎‎36.99% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover ‎‎(short ‎ratio) moved to while the shorted shares account for just 1.10% of the overall float for the ‎stock.‎‎

Humana Inc.’s Biggest Shareholders: Who Owns Humana Inc. [HUM]?

Filings by ‎The ‎Vanguard Group, Inc. showed that the firm now holds a total of 9,636,081 shares or roughly 7.28% ‎of ‎the outstanding HUM shares. This means their shares have reduced by -106,066 from the ‎‎9,636,081 ‎the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, T. Rowe ‎Price ‎Associates, Inc. updated stake is worth $3,737,933,805. Details in the latest 13F filings reveal ‎that ‎Fidelity Management & Research Co acquired their 3.49% stake valued at $2,992,819,214 ‎while ‎BlackRock Fund Advisors cut theirs at $2,598,574,561. During the last quarter, Fidelity ‎Management & ‎Research Co raised 251,745 of its shares in Humana Inc. while BlackRock Fund Advisors ‎sold -30,741 ‎shares. The SSgA Funds Management, Inc.’s holdings currently number 6,000,654 shares ‎at ‎‎$2461888316.58. According to the firm’s last 13F report, Wellington Management Co. LLP shares in ‎the ‎company at filing stood at 5,219,846 shares, roughly $2,090,652,720.‎‎

HUM Earnings Forecast ‎For The Current Quarter

Humana Inc. [HUM] is expected to report ‎weak earnings results for the ‎quarter ending on Dec 2020. Consensus estimates give the company ‎expected revenues of $18.8B and ‎an earnings per share of -$2.37 for Dec 2020. Looking further ahead, ‎the company is expected to ‎report revenue of $20.74B at an EPS of $5.84 for Mar 2021. The estimates ‎represent upside of 8.80% ‎and 16.14% in the company’s revenue and earnings per share, respectively, ‎on a year-on-year basis.‎‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

HUM Earnings Estimates For The ‎Current ‎Year

For the financial year, Humana Inc. [NYSE:HUM] is expected to bring in revenue of ‎‎$76.02B. ‎The returns are nearly $11.13 billion higher than the company’s actual revenue recorded in ‎the fiscal ‎year 2019. In terms of EPS for the 2020, estimate put it at 18.67, higher than that of FY19 by ‎‎$0.8. ‎Estimates put this year’s earnings growth at 4.50%, 16.20% for the next, and at an annual 11.98% ‎over ‎the next 5-year period. As for sales, forecasts are for an increase of 17.20% in the current fiscal ‎year ‎and a further 8.80% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Prompted INVO Biosciences’ After-Hours Rally?

A spike in INVO Bioscience, Inc's (NASDAQ: INVO) stock price after-hours drove its price up 83.28% on Monday. In regular sessions, through the end...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

Tron (TRX) Working Hard on DeFi Development; Where is TRX Heading?

Tron 2021 Global DeFi Hackathon developer contest is one of its $120 million TRON DeFi Entrepreneurial Alliance Support Program.  TRON (TRX) is making sure that it...

Mark Cuban backs Dogecoin (DOGE) and says Dallas Mavericks are the largest merchant of Meme Coin worldwide

After Elon Musk, Cuban comes out in favor of the meme coin. Dogecoin (DOGE) is one of the most anticipated cryptocurrencies of the future. Back...

The Opgen (OPGN) Stock Is High Today, Reason?

OpGen, Inc. (Nasdaq: OPGN), a company that makes use of the power of molecular diagnostics and bioinformatics to treat infectious diseases, is showing strength...

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.